Jump Financial, LLC Vaxart, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.56 - $1.41 $93,023 - $234,220	166,114 New	166,114 $215,000
Q3 2022 Nov 07, 2022	SELL	$2.09 - $4.5 $103,824 - $223,546	-49,677 Reduced 41.61%	69,723 $152,000
Q2 2022 Aug 09, 2022	BUY	$2.7 - $5.28 $5,400 - $10,560	2,000 Added 1.7%	119,400 $418,000
Q1 2022 May 12, 2022	SELL	$4.29 - $6.64 $60,308 - $93,345	-14,058 Reduced 10.69%	117,400 $592,000
Q4 2021 Feb 10, 2022	BUY	$5.77 - $7.96 $758,512 - $1.05 Million	131,458 New	131,458 $825,000
Q2 2021 Aug 13, 2021	SELL	$5.06 - $10.78 $1.1 Million - $2.35 Million	-217,887 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.64 - $23.33 $1.23 Million - $5.08 Million	217,887 New	217,887 $1.32 Million

107

37.7M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $86M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.